Literature DB >> 25331457

Margaret McCartney: What use is mass flu vaccination?

Margaret McCartney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25331457      PMCID: PMC4202689          DOI: 10.1136/bmj.g6182

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
It’s flu vaccination season again. People over 65 and those aged six months to 65 years who have a clinical risk factor (such as heart disease, asthma with regular inhaled steroid use, or chronic kidney disease) are eligible for the vaccine, along with people who live in residential care homes, pregnant women, and carers. Health and social care workers in direct contact with patients are also being encouraged to have the vaccine. But does it work?1 2 3 4 For each healthy adult, a Cochrane review found that vaccination saved an average of just 0.04 days off work and concluded that no evidence supported it as a routine public health measure.5 And among over 65s, Cochrane reviews found only poor quality data and were unable to draw conclusions of any benefit, thus recommending more trials.6 As for children, Cochrane again found the available studies to be of poor quality: the number needed to vaccinate to prevent one case ranged from seven (live vaccine) to 28 (inactivated vaccine),7 and effectiveness varied greatly depending on the season.8 The evidence is uncertain among people with asthma9; however, flu vaccination does seem to usefully reduce exacerbations in people who have chronic obstructive pulmonary disease.10 And a review of flu vaccination trials for healthcare workers who looked after older people in long term residential care found no meaningful difference in the number of cases of laboratory confirmed flu, admissions to hospital, or deaths from respiratory infections in residents.11 So, why are we vaccinating so many people in whom we have no proof that it works? We should surely be doing randomised controlled trials of the vaccine in healthy over 65s and healthcare workers, at least. The NHS has a “Flu Fighter” campaign to encourage uptake and offer incentives for staff to bare their biceps. In return for vaccination, hospitals have offered their staff entry into cash prize draws, as well as chocolates, lollipops, cakes, biscuits, stickers that read “I’m a Flu Fighter,” and even an extra day’s annual leave, some freedom of information requests have shown. But will those days off work be offset by the average 0.04 days saved through vaccination? Treating children is one thing; treating adults like children is quite another. The Department of Health wants trusts to achieve a 75% uptake in flu vaccination for staff,1 when it would be better off ensuring that resources are used where they can do some good. I would have the vaccination if a high quality trial showed that it was worth it for me or my patients. But flu vaccination is offered millions of times every year at huge opportunity cost; given so much uncertainty, this policy is impossible to justify.
  7 in total

Review 1.  Influenza vaccine for patients with chronic obstructive pulmonary disease.

Authors:  P J Poole; E Chacko; R W B Wood-Baker; C J Cates
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

Review 3.  Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions.

Authors:  Roger E Thomas; Tom Jefferson; Toby J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-22

Review 4.  Vaccines for preventing influenza in healthy children.

Authors:  Tom Jefferson; Alessandro Rivetti; Carlo Di Pietrantonj; Vittorio Demicheli; Eliana Ferroni
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 5.  Vaccines for preventing influenza in the elderly.

Authors:  Tom Jefferson; Carlo Di Pietrantonj; Lubna A Al-Ansary; Eliana Ferroni; Sarah Thorning; Roger E Thomas
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

Review 6.  Vaccines for preventing influenza in people with asthma.

Authors:  Christopher J Cates; Brian H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Lubna A Al-Ansary; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2014-03-13
  7 in total
  2 in total

1.  Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network.

Authors:  Simon de Lusignan; Uy Hoang; Harshana Liyanage; Manasa Tripathy; Julian Sherlock; Mark Joy; Filipa Ferreira; Javier Diez-Domingo; Tristan Clark
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 2.  Influenza vaccination for healthcare workers in the UK: appraisal of systematic reviews and policy options.

Authors:  Merav Kliner; Alex Keenan; David Sinclair; Sam Ghebrehewet; Paul Garner
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.